JBNm Scaffold

About Eascra Biotech

Eascra Biotech is a private, preclinical-stage biotech founded in 2020 and based in Boston. The company has developed a proprietary, non-lipid nanoparticle platform (JBNps) inspired by DNA structures, enabling room-temperature stable delivery of therapeutics into dense tissues like cartilage and solid tumors. Its pipeline includes a therapeutic delivery platform (JBNp) and an orthopedic scaffold (JBNm), with initial focus on osteoarthritis and oncology. Eascra operates as a platform/therapeutics company and is currently pre-revenue, leveraging partnerships for development.

Therapeutic Areas